This article has been updated from a previous version to include comments from Trovagene's Q3 earnings call.

NEW YORK (GenomeWeb) – Trovagene reported after the close of the market on Monday flat year-over-year third quarter revenues as it trimmed its net loss in half.

For the three months ended Sept. 30, 2015, the San Diego-based molecular diagnostics developer reported $57,000 in revenues. The company reported $51,000 in royalty revenue compared to $57,000 a year ago, and $6,000 in diagnostic service revenue compared to none in Q3 2014.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.